Literature DB >> 26855169

Characteristics of antiretroviral therapy-naïve patients lost-to-care in HIV clinics in Democratic Republic of Congo, Cameroon, and Burundi.

Kristen Stolka1, Jeniffer Iriondo-Perez1, Modeste Kiumbu2, Joseph Atibu2, Innocent Azinyue3, Wilfred Akam4, Ashue Balimba5, Brigitte Mfangam Molu6, Henri Mukumbi7, Theodore Niyongabo8, Christelle Twizere8, Jamie Newman1, Jennifer Hemingway-Foday1.   

Abstract

Antiretroviral therapy (ART)-naïve patients are vulnerable to becoming lost-to-care (LTC) because they are not monitored as often as patients on treatment. We examined data from 19,461 HIV positive adults at 10 HIV clinics in Democratic Republic of Congo (DRC), Cameroon, and Burundi participating in the Phase 1 International epidemiologic Databases to Evaluate AIDS Central Africa (IeDEA-CA) study. Patients were LTC if they were ART-naïve and did not return within 7 months of the end of data collection. Logistic regression was used to obtain odds ratios (ORs) and 95% confidence intervals (CIs) for risk factors associated with LTC. Of 5353 ART-naïve patients, 4420 (83%) were LTC and 933 (17%) were in-care. The odds of being LTC were greatest among patients from DRC (OR = 2.16, CI: 1.64-2.84, p < .0001), males (OR = 1.39, CI: 1.15-1.69, p = .0009), and ages 18-49 (OR = 1.45, CI: 1.16-1.82, p = .001). The odds of being LTC were least among patients with a WHO Clinical Stage of 1 or 2 (OR = 0.65, CI: 0.55-0.77, p < .0001) and in a perceived concordant relationship (OR = 0.61, CI: 0.43-0.87, p < .0001). LTC patients were more likely to have characteristics associated with higher risk for HIV transmission and progression. Many entered care at advanced stages and were less likely to know their partner's serostatus. Greater efforts to retain ART-naïve patients may increase earlier initiation of ART.

Entities:  

Keywords:  ART-naïve; Central Africa; HIV; lost-to-care

Mesh:

Year:  2016        PMID: 26855169     DOI: 10.1080/09540121.2015.1124982

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  4 in total

1.  Prevalence, trend and risk factors for antiretroviral therapy discontinuation among HIV-infected adults in Ethiopia in 2003-2015.

Authors:  Hailay Abrha Gesesew; Paul Ward; Kifle Woldemichael; Lillian Mwanri
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

2.  Characteristics of HIV-Infected Children at Enrollment into Care and at Antiretroviral Therapy Initiation in Central Africa.

Authors:  Adebola Adedimeji; Andrew Edmonds; Donald Hoover; Qiuhu Shi; Jean d'Amour Sinayobye; Martin Nduwimana; Patricia Lelo; Denis Nash; Kathryn Anastos; Marcel Yotebieng
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

3.  Firth's Logistic Regression of Interruption in Treatment before and after the Onset of COVID-19 among People Living with HIV on ART in Two Provinces of DRC.

Authors:  Gulzar H Shah; Gina D Etheredge; Jessica S Schwind; Lievain Maluantesa; Kristie C Waterfield; Astrid Mulenga; Osaremhen Ikhile; Elodie Engetele; Elizabeth Ayangunna
Journal:  Healthcare (Basel)       Date:  2022-08-12

4.  Predictors of retention in the prospective HIV prevention OKAPI cohort in Kinshasa.

Authors:  S Carlos; E Burgueño; A Ndarabu; G Reina; C Lopez-Del Burgo; A Osorio; B Makonda; J de Irala
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.